Product details
Background：phosphate-buffered solution, pH 7.2-7.4.
U-Blot® IL-12/23(p40) hIgG1 Reference Antibody (Ustebio)
UcallM
$999.00
Specifications
| Target | IL-12& IL-23 |
| Reactivity | |
| Applications | Ustekinumab (brand name: Stelara) is a fully human IgG1κ monoclonal antibody developed by Janssen Biotech, a subsidiary of Johnson & Johnson. It is used to treat various immune-mediated diseases, such as psoriasis, psoriatic arthritis, and Crohn's disease. It exerts its immunomodulatory effects by specifically inhibiting the activity of the pro-inflammatory cytokines IL-12 and IL-23. |
| MW(Calculated) | |
| MW(Observed) | |
| Host Species | Human |
| Isotype | IgG1, |
| Conjugate/Modification | Unconjugated |
| Modification | |
| Recommended Dilution Ratio | |
| Formulation Buffer | phosphate-buffered solution, pH 7.4. |
| Source | |
| Purification | |
| Purity | > 95% as determined by SDS-PAGE |
| Storage | Store at 2-8℃ short term (1-2 weeks).Store at ≤ -94℃ long term.Avoid repeated freeze-thaw. |
| Concentration | |
| Clonality | Monoclonal |
| Clone Number | Ustekinumab |
| Immunogen | |
| Sequence | |
| Specificity | |
| Gene Name | |
| Protein Name | |
| Other Name | |
| Species | |
| Gene ID | |
| Uniprot | |
| Species.1 | |
| Gene ID.1 | |
| Uniprot.1 | |
| Species.2 | |
| Gene ID.2 | |
| Uniprot.2 | |
| Organism-4 | |
| GeneID-4 | |
| SwissProt-4 | |
| Cellular Localization | |
| Tissue Expression | |
| Signaling_pathway | |
| Research Areas | |
| Function | |
| RRID |
Please login to post questions
Related products
